[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Medical News & Perspectives
May 19, 1999

Drug Doings Down Under

Author Affiliations

Not Available

Not Available

JAMA. 1999;281(19):1782-1783. doi:10.1001/jama.281.19.1782-JMN0519-3-1

Sydney—Weeks of acrimonious debate about heroin in Australia have culminated in a large injection of funds into drug treatment, diversionary programs to keep users out of prison, and maintenance of the country's internationally applauded harm minimization program.

Over the past few months, several factors have come together to put intravenous drug use on the front page of newspapers almost constantly. Low heroin prices, increasing numbers of young users, and a rise in heroin-related mortality, which now exceeds road trauma as a cause of death in young people, formed the background to the politicians' positions.

First Page Preview View Large
First page PDF preview
First page PDF preview